-
Genomic assay in HR+/HER2- breast cancer; what we know and what we don't know_Kevin Kalinsky, MD, MS; #DDHO2021
4:29
-
Management of the axilla in breast cancer_Cletus Arciero, MD, FACS; #DDHO2021
2:04
-
Virginia Kaklamani, MD, DSc; UT Health San Antonio, MD Anderson Cancer Center; 5Live; #ASCO2021
5:04
-
Adam M. Brufsky, MD, PhD; UPMC Hillman Cancer Center University of Pittsburgh; 5Live; #ASCO2021
6:32
-
William J. Gradishar, MD, FASCO, FACP; Robert H. Lurie Comprehensive Cancer Center; 5Live; #ASCO2021
5:11
-
Optimizing Breast Cancer Care: The Patient Perspective_Julia Maues_Promo
0:45
-
Optimizing Breast Cancer Care: The Patient Perspective_Sheila McGlown_Promo
0:53
-
Disparities in Triple Negative Breast Cancer_Edith Mitchell, MD, MACP, FCPP, FRCP (London) & Lisa Newman, MD, MPH, FACS, FASCO, FSSO
39:24
-
Optimizing Breast Cancer Care: The Patient Perspective_Sheila McGlown and Julia Maues
11:15
-
Mark Pegram, MD; Stanford Health Care; 5Live #SABCS20
6:13
Key insights from the 2020 Annual Breast meeting in San Antonio
-
Sara Hurvitz, MD, University of California Los Angeles; 5Live #SABCS20
6:30
Key insights from the 2020 Annual Breast meeting in San Antonio
- Next Page
